Through investments made by the Bipartisan Safer Communities Act (BSCA), the grants will be awarded to 20 states of up to $2.5 million to support the implementation, improvement and expansion of school-based health services through Medicaid and the Children’s Health Insurance Program (CHIP).
Read More
Antiretroviral Therapy Tamed the HIV/AIDS Epidemic. The Mortality Stats Show It.
January 28th 2024Data from 17 longitudinal studies of adults with HIV treated with antiretroviral therapy how that proportion of deaths caused by AIDS has fallen from nearly 50% to 16% and that all-cause mortality has been sliced in half.
Read More
Trodelvy Falls Short As NSCLC Treatment, Taking Some of the Shine Off Antibody-Drug Conjugates
January 23rd 2024Gilead's share price fell 10% today after it announced that Trodelvy, an antibody-drug conjugate, failed to meet its overall survival end point in a trial testing it as treatment for metatstatic non-small cell lung cancer.
Read More
Vtama Is Getting Ready to Elbow Its Way Into the Crowded Field of Atopic Dermatitis Medications
January 19th 2024The FDA approved Dermavant Science's Vtama (tapinarof cream) last year as a treatment for plaque psoriasis. Sales have been disappointing, according to press reports. Will Vtama, which has a different mechanism of action than the current batch of topical medications for atopic dermatitis, fare better in the atopic dermatitis market?
Read More
Leukemia Death, Survival Trends Are Improving in the Era of Targeted Treatment
January 18th 2024The outlook for leukemia patients improved after Gleevec (imatinib) was approved in 2001 as a treatment for chronic myeloid leukemia. The American Cancer Society published its annual cancer statistics report today that projects 62,770 new cases of leukemia will be diagnosed this year and 23,670 deaths from the disease will occur.
Read More